Trials / Unknown
UnknownNCT04622202
Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section
The Effects Of Pre-emptive Single Oral Dose Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 74 (estimated)
- Sponsor
- Zagazig University · Other Government
- Sex
- Female
- Age
- 21 Years – 38 Years
- Healthy volunteers
- Accepted
Summary
There is exaggerated neuroendocrine stress response to laryngoscopy and endotracheal intubation during the Induction to anesthesia-delivery (I-D) period under light anesthesia. Mechanical stimulation of laryngeal proprioceptors elicits increased secretion of cortisol and catecholamine with subsequent elevation of blood pressure from 40 to 50 % and heart rate up to 20 % during direct laryngoscopy and endotracheal intubation
Detailed description
The sample size was calculated using OPEN EPI program assuming that the mean visual analogue scale anxiety score was 49.3±14.1 among oral pregabalin group and was 58.6± 14.4 among Placebo group (8) so at power of study 80% confidence interval 95%, the sample size was calculated to be 74 cases (37in each group
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin 150mg | oral capsule pregabalin 150 mg. |
| DRUG | multivitamin | oral placebo in the form of oral multivitamin capsule. |
Timeline
- Start date
- 2020-11-15
- Primary completion
- 2021-02-28
- Completion
- 2021-03-01
- First posted
- 2020-11-09
- Last updated
- 2021-02-04
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04622202. Inclusion in this directory is not an endorsement.